Suchergebnisse - "Saravanan, Kappusamy"

PubPharm (7)

1

enthalten in: Europäisches Patentamt | 2023

von JAMES MCCHESNEY | ANNIE BOUCHARD | SARAVANAN KAPPUSAMY | +2

2

1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity

enthalten in: Journal of medicinal chemistry | 2013

von Cano, C. | Saravanan, K. | Bailey, C. | +14

3

1-Substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones Endowed with Dual DNA-PK/PI3-K Inhibitory Activity

enthalten in: Journal of medicinal chemistry | 2013

von Cano, C. | Saravanan, K. | Bailey, C. | +14

4

Nucleoside transport inhibitors : structure-activity relationships for pyrimido[5,4-d]pyrimidine derivatives that potentiate pemetrexed cytotoxicity in the presence of α1-acid glycoprotein

enthalten in: Journal of medicinal chemistry | 2011

von Saravanan, K. | Barlow, H. | Barton, M. | +7

5

Nucleoside Transport Inhibitors: Structure−Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of α1-Acid Glycoprotein

enthalten in: Journal of medicinal chemistry | 2011

von Saravanan, K. | Barlow, H. | Barton, M. | +7

6

Preclinical evaluation of a novel pyrimidopyrimidine for the prevention of nucleoside and nucleobase reversal of antifolate cytotoxicity

enthalten in: Molecular cancer therapeutics | 2009

von Thomas, H. | Saravanan, K. | Wang, L. | +8

7

Preclinical evaluation of a novel pyrimidopyrimidine for the prevention of nucleoside and nucleobase reversal of antifolate cytotoxicity

enthalten in: Molecular cancer therapeutics | 2009

von Thomas, H. | Saravanan, K. | Wang, L. | +8

1
[1]